nodes	percent_of_prediction	percent_of_DWPC	metapath
Allopurinol—XDH—Cisplatin—peripheral nervous system neoplasm	0.302	0.599	CbGbCtD
Allopurinol—XDH—Doxorubicin—peripheral nervous system neoplasm	0.202	0.401	CbGbCtD
Allopurinol—AOX1—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0239	0.424	CbGpPWpGaD
Allopurinol—XDH—Effects of Nitric Oxide—MB—peripheral nervous system neoplasm	0.0222	0.394	CbGpPWpGaD
Allopurinol—XDH—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00206	0.0366	CbGpPWpGaD
Allopurinol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00104	0.0184	CbGpPWpGaD
Allopurinol—SLC22A7—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000444	0.00787	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000431	0.00764	CbGpPWpGaD
Allopurinol—XDH—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000401	0.0071	CbGpPWpGaD
Allopurinol—SLC22A7—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000331	0.00587	CbGpPWpGaD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000318	0.00564	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000291	0.00516	CbGpPWpGaD
Allopurinol—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000278	0.00493	CbGpPWpGaD
Allopurinol—XDH—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000271	0.0048	CbGpPWpGaD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000267	0.00474	CbGpPWpGaD
Allopurinol—AOX1—Disease—GNS—peripheral nervous system neoplasm	0.000251	0.00445	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—GNS—peripheral nervous system neoplasm	0.00021	0.00373	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—NME1—peripheral nervous system neoplasm	0.000202	0.00358	CbGpPWpGaD
Allopurinol—XDH—Metabolism—GNS—peripheral nervous system neoplasm	0.000196	0.00347	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—COX2—peripheral nervous system neoplasm	0.000194	0.00344	CbGpPWpGaD
Allopurinol—XDH—Metabolism—NME1—peripheral nervous system neoplasm	0.000188	0.00332	CbGpPWpGaD
Allopurinol—XDH—Metabolism—COX2—peripheral nervous system neoplasm	0.000181	0.0032	CbGpPWpGaD
Allopurinol—AOX1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000176	0.00312	CbGpPWpGaD
Allopurinol—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000386	CcSEcCtD
Allopurinol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000169	0.000386	CcSEcCtD
Allopurinol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000169	0.000386	CcSEcCtD
Allopurinol—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000385	CcSEcCtD
Allopurinol—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000384	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000168	0.00298	CbGpPWpGaD
Allopurinol—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000168	0.000382	CcSEcCtD
Allopurinol—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000167	0.000381	CcSEcCtD
Allopurinol—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00038	CcSEcCtD
Allopurinol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000167	0.00038	CcSEcCtD
Allopurinol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000167	0.00038	CcSEcCtD
Allopurinol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000166	0.000378	CcSEcCtD
Allopurinol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000165	0.000376	CcSEcCtD
Allopurinol—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000375	CcSEcCtD
Allopurinol—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000374	CcSEcCtD
Allopurinol—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000374	CcSEcCtD
Allopurinol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000371	CcSEcCtD
Allopurinol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000163	0.000371	CcSEcCtD
Allopurinol—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.00037	CcSEcCtD
Allopurinol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000369	CcSEcCtD
Allopurinol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000162	0.000368	CcSEcCtD
Allopurinol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000367	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000367	CcSEcCtD
Allopurinol—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000364	CcSEcCtD
Allopurinol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00016	0.000364	CcSEcCtD
Allopurinol—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000364	CcSEcCtD
Allopurinol—Pain—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000363	CcSEcCtD
Allopurinol—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000359	CcSEcCtD
Allopurinol—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000359	CcSEcCtD
Allopurinol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000157	0.000358	CcSEcCtD
Allopurinol—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000357	CcSEcCtD
Allopurinol—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000355	CcSEcCtD
Allopurinol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000155	0.000354	CcSEcCtD
Allopurinol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000353	CcSEcCtD
Allopurinol—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000352	CcSEcCtD
Allopurinol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000154	0.00035	CcSEcCtD
Allopurinol—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000153	0.00035	CcSEcCtD
Allopurinol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000349	CcSEcCtD
Allopurinol—AOX1—Disease—ENO2—peripheral nervous system neoplasm	0.000152	0.0027	CbGpPWpGaD
Allopurinol—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000346	CcSEcCtD
Allopurinol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000152	0.000346	CcSEcCtD
Allopurinol—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000346	CcSEcCtD
Allopurinol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000151	0.000345	CcSEcCtD
Allopurinol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000342	CcSEcCtD
Allopurinol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00015	0.000342	CcSEcCtD
Allopurinol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00015	0.000341	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000339	CcSEcCtD
Allopurinol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000149	0.000339	CcSEcCtD
Allopurinol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000149	0.000338	CcSEcCtD
Allopurinol—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000337	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000148	0.000336	CcSEcCtD
Allopurinol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000336	CcSEcCtD
Allopurinol—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000335	CcSEcCtD
Allopurinol—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000334	CcSEcCtD
Allopurinol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000334	CcSEcCtD
Allopurinol—Pain—Etoposide—peripheral nervous system neoplasm	0.000146	0.000333	CcSEcCtD
Allopurinol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000146	0.000333	CcSEcCtD
Allopurinol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000333	CcSEcCtD
Allopurinol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000333	CcSEcCtD
Allopurinol—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000332	CcSEcCtD
Allopurinol—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000332	CcSEcCtD
Allopurinol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.00033	CcSEcCtD
Allopurinol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000144	0.000329	CcSEcCtD
Allopurinol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000328	CcSEcCtD
Allopurinol—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000326	CcSEcCtD
Allopurinol—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000324	CcSEcCtD
Allopurinol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000323	CcSEcCtD
Allopurinol—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000323	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000141	0.00251	CbGpPWpGaD
Allopurinol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000141	0.000321	CcSEcCtD
Allopurinol—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00032	CcSEcCtD
Allopurinol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00014	0.00032	CcSEcCtD
Allopurinol—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000319	CcSEcCtD
Allopurinol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00014	0.000318	CcSEcCtD
Allopurinol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00014	0.000318	CcSEcCtD
Allopurinol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000317	CcSEcCtD
Allopurinol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000317	CcSEcCtD
Allopurinol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000314	CcSEcCtD
Allopurinol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000138	0.000314	CcSEcCtD
Allopurinol—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000314	CcSEcCtD
Allopurinol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000313	CcSEcCtD
Allopurinol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000313	CcSEcCtD
Allopurinol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000137	0.000312	CcSEcCtD
Allopurinol—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00031	CcSEcCtD
Allopurinol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000136	0.000309	CcSEcCtD
Allopurinol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000309	CcSEcCtD
Allopurinol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000309	CcSEcCtD
Allopurinol—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000309	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000135	0.0024	CbGpPWpGaD
Allopurinol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Allopurinol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Allopurinol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Allopurinol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Allopurinol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000308	CcSEcCtD
Allopurinol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000307	CcSEcCtD
Allopurinol—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000307	CcSEcCtD
Allopurinol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000306	CcSEcCtD
Allopurinol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000134	0.000306	CcSEcCtD
Allopurinol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000134	0.000305	CcSEcCtD
Allopurinol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000305	CcSEcCtD
Allopurinol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000304	CcSEcCtD
Allopurinol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000303	CcSEcCtD
Allopurinol—Rash—Vincristine—peripheral nervous system neoplasm	0.000133	0.000303	CcSEcCtD
Allopurinol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000133	0.000303	CcSEcCtD
Allopurinol—SLC22A7—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000133	0.00235	CbGpPWpGaD
Allopurinol—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000302	CcSEcCtD
Allopurinol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000301	CcSEcCtD
Allopurinol—Headache—Vincristine—peripheral nervous system neoplasm	0.000132	0.000301	CcSEcCtD
Allopurinol—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000299	CcSEcCtD
Allopurinol—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000299	CcSEcCtD
Allopurinol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000296	CcSEcCtD
Allopurinol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000296	CcSEcCtD
Allopurinol—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000295	CcSEcCtD
Allopurinol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000128	0.000291	CcSEcCtD
Allopurinol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00029	CcSEcCtD
Allopurinol—AOX1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000128	0.00226	CbGpPWpGaD
Allopurinol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000289	CcSEcCtD
Allopurinol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000287	CcSEcCtD
Allopurinol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000126	0.000287	CcSEcCtD
Allopurinol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000286	CcSEcCtD
Allopurinol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000286	CcSEcCtD
Allopurinol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000125	0.000285	CcSEcCtD
Allopurinol—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000285	CcSEcCtD
Allopurinol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000285	CcSEcCtD
Allopurinol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000285	CcSEcCtD
Allopurinol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000284	CcSEcCtD
Allopurinol—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000284	CcSEcCtD
Allopurinol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000283	CcSEcCtD
Allopurinol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000282	CcSEcCtD
Allopurinol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000281	CcSEcCtD
Allopurinol—AOX1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000123	0.00218	CbGpPWpGaD
Allopurinol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000123	0.000279	CcSEcCtD
Allopurinol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000279	CcSEcCtD
Allopurinol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000277	CcSEcCtD
Allopurinol—Chills—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000276	CcSEcCtD
Allopurinol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000121	0.000275	CcSEcCtD
Allopurinol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000274	CcSEcCtD
Allopurinol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000271	CcSEcCtD
Allopurinol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000119	0.00027	CcSEcCtD
Allopurinol—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	0.000119	0.0021	CbGpPWpGaD
Allopurinol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Allopurinol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000269	CcSEcCtD
Allopurinol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000268	CcSEcCtD
Allopurinol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000268	CcSEcCtD
Allopurinol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000267	CcSEcCtD
Allopurinol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000117	0.000266	CcSEcCtD
Allopurinol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000266	CcSEcCtD
Allopurinol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000265	CcSEcCtD
Allopurinol—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000264	CcSEcCtD
Allopurinol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000264	CcSEcCtD
Allopurinol—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000263	CcSEcCtD
Allopurinol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000262	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000114	0.00202	CbGpPWpGaD
Allopurinol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000113	0.000257	CcSEcCtD
Allopurinol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000257	CcSEcCtD
Allopurinol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000255	CcSEcCtD
Allopurinol—SLC22A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000112	0.00198	CbGpPWpGaD
Allopurinol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000252	CcSEcCtD
Allopurinol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000251	CcSEcCtD
Allopurinol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000249	CcSEcCtD
Allopurinol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000248	CcSEcCtD
Allopurinol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000109	0.000248	CcSEcCtD
Allopurinol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000247	CcSEcCtD
Allopurinol—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000247	CcSEcCtD
Allopurinol—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000246	CcSEcCtD
Allopurinol—Rash—Etoposide—peripheral nervous system neoplasm	0.000108	0.000245	CcSEcCtD
Allopurinol—AOX1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000108	0.00191	CbGpPWpGaD
Allopurinol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000108	0.000245	CcSEcCtD
Allopurinol—Headache—Etoposide—peripheral nervous system neoplasm	0.000107	0.000244	CcSEcCtD
Allopurinol—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000244	CcSEcCtD
Allopurinol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000242	CcSEcCtD
Allopurinol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000241	CcSEcCtD
Allopurinol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000105	0.00024	CcSEcCtD
Allopurinol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000239	CcSEcCtD
Allopurinol—AOX1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000103	0.00182	CbGpPWpGaD
Allopurinol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000232	CcSEcCtD
Allopurinol—Nausea—Etoposide—peripheral nervous system neoplasm	0.000102	0.000231	CcSEcCtD
Allopurinol—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000231	CcSEcCtD
Allopurinol—AOX1—Metabolism—TH—peripheral nervous system neoplasm	0.000101	0.0018	CbGpPWpGaD
Allopurinol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00023	CcSEcCtD
Allopurinol—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000229	CcSEcCtD
Allopurinol—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	0.0001	0.00178	CbGpPWpGaD
Allopurinol—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000228	CcSEcCtD
Allopurinol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000228	CcSEcCtD
Allopurinol—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.000227	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.93e-05	0.000226	CcSEcCtD
Allopurinol—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.88e-05	0.000225	CcSEcCtD
Allopurinol—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000223	CcSEcCtD
Allopurinol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000222	CcSEcCtD
Allopurinol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000221	CcSEcCtD
Allopurinol—Confusional state—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.00022	CcSEcCtD
Allopurinol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000218	CcSEcCtD
Allopurinol—Oedema—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000218	CcSEcCtD
Allopurinol—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.55e-05	0.00169	CbGpPWpGaD
Allopurinol—Infection—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000217	CcSEcCtD
Allopurinol—XDH—Metabolism—TH—peripheral nervous system neoplasm	9.42e-05	0.00167	CbGpPWpGaD
Allopurinol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	9.41e-05	0.000214	CcSEcCtD
Allopurinol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.000214	CcSEcCtD
Allopurinol—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.38e-05	0.000214	CcSEcCtD
Allopurinol—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000214	CcSEcCtD
Allopurinol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000212	CcSEcCtD
Allopurinol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	9.26e-05	0.000211	CcSEcCtD
Allopurinol—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000211	CcSEcCtD
Allopurinol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000211	CcSEcCtD
Allopurinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000209	CcSEcCtD
Allopurinol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.14e-05	0.000208	CcSEcCtD
Allopurinol—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000208	CcSEcCtD
Allopurinol—Hypotension—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000204	CcSEcCtD
Allopurinol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000204	CcSEcCtD
Allopurinol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000202	CcSEcCtD
Allopurinol—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000202	CcSEcCtD
Allopurinol—Infection—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000201	CcSEcCtD
Allopurinol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.73e-05	0.000199	CcSEcCtD
Allopurinol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000198	CcSEcCtD
Allopurinol—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.68e-05	0.000198	CcSEcCtD
Allopurinol—Insomnia—Epirubicin—peripheral nervous system neoplasm	8.67e-05	0.000197	CcSEcCtD
Allopurinol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000196	CcSEcCtD
Allopurinol—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.6e-05	0.000196	CcSEcCtD
Allopurinol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000195	CcSEcCtD
Allopurinol—Somnolence—Epirubicin—peripheral nervous system neoplasm	8.52e-05	0.000194	CcSEcCtD
Allopurinol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.000192	CcSEcCtD
Allopurinol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000192	CcSEcCtD
Allopurinol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.00019	CcSEcCtD
Allopurinol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000189	CcSEcCtD
Allopurinol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000188	CcSEcCtD
Allopurinol—AOX1—Metabolism—GNAS—peripheral nervous system neoplasm	8.27e-05	0.00147	CbGpPWpGaD
Allopurinol—Constipation—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000187	CcSEcCtD
Allopurinol—Pain—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000187	CcSEcCtD
Allopurinol—AOX1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.11e-05	0.00144	CbGpPWpGaD
Allopurinol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.08e-05	0.000184	CcSEcCtD
Allopurinol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000183	CcSEcCtD
Allopurinol—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.000181	CcSEcCtD
Allopurinol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.00018	CcSEcCtD
Allopurinol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	7.88e-05	0.00018	CcSEcCtD
Allopurinol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000178	CcSEcCtD
Allopurinol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000178	CcSEcCtD
Allopurinol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000176	CcSEcCtD
Allopurinol—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	7.69e-05	0.00136	CbGpPWpGaD
Allopurinol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000174	CcSEcCtD
Allopurinol—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.61e-05	0.000173	CcSEcCtD
Allopurinol—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000173	CcSEcCtD
Allopurinol—Pain—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000173	CcSEcCtD
Allopurinol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000173	CcSEcCtD
Allopurinol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000173	CcSEcCtD
Allopurinol—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	7.54e-05	0.00134	CbGpPWpGaD
Allopurinol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000166	CcSEcCtD
Allopurinol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000165	CcSEcCtD
Allopurinol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000161	CcSEcCtD
Allopurinol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.04e-05	0.00016	CcSEcCtD
Allopurinol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.00016	CcSEcCtD
Allopurinol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.00016	CcSEcCtD
Allopurinol—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000157	CcSEcCtD
Allopurinol—AOX1—Disease—PTPN11—peripheral nervous system neoplasm	6.86e-05	0.00122	CbGpPWpGaD
Allopurinol—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.78e-05	0.000154	CcSEcCtD
Allopurinol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000149	CcSEcCtD
Allopurinol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000149	CcSEcCtD
Allopurinol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000145	CcSEcCtD
Allopurinol—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000144	CcSEcCtD
Allopurinol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000143	CcSEcCtD
Allopurinol—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000139	CcSEcCtD
Allopurinol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000138	CcSEcCtD
Allopurinol—Rash—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000138	CcSEcCtD
Allopurinol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000137	CcSEcCtD
Allopurinol—Headache—Epirubicin—peripheral nervous system neoplasm	6e-05	0.000137	CcSEcCtD
Allopurinol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000134	CcSEcCtD
Allopurinol—Nausea—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.00013	CcSEcCtD
Allopurinol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.000128	CcSEcCtD
Allopurinol—Rash—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000127	CcSEcCtD
Allopurinol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000127	CcSEcCtD
Allopurinol—Headache—Doxorubicin—peripheral nervous system neoplasm	5.55e-05	0.000127	CcSEcCtD
Allopurinol—AOX1—Disease—ERBB2—peripheral nervous system neoplasm	5.42e-05	0.000961	CbGpPWpGaD
Allopurinol—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.00012	CcSEcCtD
Allopurinol—AOX1—Disease—NRAS—peripheral nervous system neoplasm	4.13e-05	0.000731	CbGpPWpGaD
Allopurinol—AOX1—Disease—MYC—peripheral nervous system neoplasm	3.84e-05	0.000681	CbGpPWpGaD
Allopurinol—AOX1—Disease—HRAS—peripheral nervous system neoplasm	3.02e-05	0.000535	CbGpPWpGaD
Allopurinol—AOX1—Disease—AKT1—peripheral nervous system neoplasm	2.67e-05	0.000472	CbGpPWpGaD
Allopurinol—AOX1—Metabolism—AKT1—peripheral nervous system neoplasm	2.23e-05	0.000396	CbGpPWpGaD
Allopurinol—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	2.07e-05	0.000368	CbGpPWpGaD
